Lc. Bailey et Na. Levine, OPTIMIZATION OF THE USP ASSAY FOR HYALURONIDASE, Journal of pharmaceutical and biomedical analysis, 11(4-5), 1993, pp. 285-292
The current USP XXII assay for hyaluronidase (EC 3.2.1.35, HAse) deter
mines activity indirectly by measuring the amount of undegraded hyalur
onic acid (HA) substrate remaining after the enzyme is allowed to reac
t with the HA for 30 min at 37-degrees-C. To be acceptable as a substr
ate, the HA must pass a USP suitability test. In this study, seven HA
samples, which differed in their anatomical origin, their commercial s
upplier, and their chondroitin sulphate content, were tested as substr
ates. One of these did not pass the USP suitability test and therefore
would not be an officially acceptable substrate; however, it was carr
ied through the investigation along with the others in order to demons
trate its effect on the analysis. All seven HAs were used as substrate
s to assay testicular hyaluronidases from three different suppliers. T
he standard by which the other hyaluronidase activities were measured
was USP hyaluronidase reference standard. The activity values calculat
ed for a particular hyaluronidase differed significantly depending on
which HA was used as substrate in its assay. Optimal results, as judge
d on the bases of initial purity, suitability for the assay, linearity
of the standard curve, and per cent relative standard deviation of th
e measured activity, were obtained with a HA substrate derived from vi
treous humour.